DEUTSCHE BANK AG\

Bank

Position in XFOR — X4 Pharmaceuticals, Inc

CIK 948046 FRANKFURT AM MAIN, 2M

Position in XFOR

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$368,392

+$305,233 QoQ

Shares Held

78,885

+784.3% QoQ

Ownership

0.080%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#37

of 89 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

DEUTSCHE BANK AG\ holds $3,199,137,357 across 296 Biotechnology names. XFOR ranks #199 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,579,110	$784,391,303
2	REGN	Regeneron Pharmaceuticals, Inc.	518,409	$323,248,743
3	ALNY	Alnylam Pharmaceuticals, Inc.	815,400	$245,459,858
4	RVMD	Revolution Medicines, Inc.	888,019	$166,308,196
5	RPRX	Royalty Pharma plc	2,717,951	$152,395,510
6	INCY	Incyte Corp	1,262,988	$143,172,312
7	ARGX	Argenx SE	137,335	$127,415,291
8	LGND	Ligand Pharmaceuticals Inc	249,611	$78,899,539

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$368,392	78,885	-70.5%	Shares	Defined	2026-08-07
2025-03-31	$63,159	267,628	0.0%	Shares	Defined	2025-05-09
2024-12-31	$196,438	267,628	+559.6%	Shares	Defined	2025-06-30
2024-09-30	$27,145	40,577	0.0%	Shares	Defined	2025-06-26
2024-06-30	$23,533	40,577	-23.1%	Shares	Defined	2025-06-12
2024-03-31	$73,376	52,789	-13.8%	Shares	Defined	2025-06-02
2023-09-30	$66,737	61,227	0.0%	Shares	Defined	2023-11-24
2023-06-30	$118,780	61,227	+486.5%	Shares	Defined	2023-08-14
2021-03-31	$89,879	10,439	-8.5%	Shares	Defined	2021-05-13
2020-12-31	$73,372	11,411	+39.6%	Shares	Defined	2021-02-16
2020-09-30	$55,324	8,172	+7.5%	Shares	Defined	2020-11-12
2020-06-30	$70,830	7,600	+36.3%	Shares	Defined	2020-08-13
2020-03-31	$55,768	5,577	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.